Lemaitre Vascular (LMAT) Tops Q3 EPS by 5c

Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.49, $0.05 better than the analyst estimate of $0.44. Revenue for the quarter came in at $54.8 million versus the consensus estimate of $53.5 million.

GUIDANCE:

Lemaitre Vascular sees FY2024 EPS of $1.91-$1.96, versus the consensus of $1.85. Lemaitre Vascular sees FY2024 revenue of $219-221 million, versus the consensus of $218.3 million.

Lemaitre Vascular sees FY2024 EPS of $0.47-$0.51, versus the consensus of $0.46. Lemaitre Vascular sees FY2024 revenue of $54.9-56.9 million, versus the consensus of $55.6 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• KLX Energy narrows Q3 2026 revenue guidance, completes rights offering
• HeartSciences (HSCS) files $200M mixed shelf